Torrent Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE685A01028
  • NSEID: TORNTPHARM
  • BSEID: 500420
INR
4,181.40
-86.35 (-2.02%)
BSENSE

Mar 23

BSE+NSE Vol: 77.74 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
3,303.00
3,302.00
3,178.00
2,959.00
2,809.00
2,889.00
2,859.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,303.00
3,302.00
3,178.00
2,959.00
2,809.00
2,889.00
2,859.00
Raw Material Cost
414.00
382.00
396.00
402.00
370.00
337.00
411.00
Purchase of Finished goods
422.00
382.00
338.00
416.00
420.00
382.00
313.00
(Increase) / Decrease In Stocks
-37.00
36.00
40.00
-87.00
-117.00
-41.00
-30.00
Employee Cost
651.00
627.00
605.00
561.00
549.00
543.00
550.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
765.00
792.00
767.00
703.00
673.00
729.00
711.00
Total Expenditure (Excl Depreciation)
2,215.00
2,219.00
2,146.00
1,995.00
1,895.00
1,950.00
1,955.00
Operating Profit (PBDIT) excl Other Income
1,088.00
1,083.00
1,032.00
964.00
914.00
939.00
904.00
Other Income
-13.00
-27.00
-37.00
-18.00
33.00
-16.00
24.00
Operating Profit (PBDIT)
1,075.00
1,056.00
995.00
946.00
947.00
923.00
928.00
Interest
45.00
48.00
56.00
56.00
57.00
64.00
75.00
Exceptional Items
-10.00
-13.00
0.00
-24.00
0.00
0.00
0.00
Gross Profit (PBDT)
1,020.00
995.00
939.00
866.00
890.00
859.00
853.00
Depreciation
206.00
204.00
201.00
201.00
199.00
198.00
197.00
Profit Before Tax
814.00
791.00
738.00
665.00
691.00
661.00
656.00
Tax
179.00
200.00
190.00
167.00
188.00
208.00
199.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
635.00
591.00
548.00
498.00
503.00
453.00
457.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
635.00
591.00
548.00
498.00
503.00
453.00
457.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
635.00
591.00
548.00
498.00
503.00
453.00
457.00
Equity Capital
169.23
169.23
169.23
169.23
169.23
169.23
169.23
Face Value
5.0
5.0
5.0
5.0
5.0
5.0
5.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
18.76
17.46
16.19
14.71
14.86
13.38
13.5
Diluted Earnings per share
18.77
17.54
16.19
14.71
14.88
13.37
13.51
Operating Profit Margin (Excl OI)
33.47%
33.36%
32.99%
33.14%
33.09%
33.17%
32.11%
Gross Profit Margin
31.37%
30.65%
30.02%
29.77%
32.22%
30.34%
30.3%
PAT Margin
19.53%
18.21%
17.52%
17.12%
18.21%
16.0%
16.23%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 0.03% vs 3.90% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 7.45% vs 7.85% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 0.46% vs 4.94% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is -6.25% vs -14.29% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Torrent Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
3,303.00
2,604.00
699.00
26.84%
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,303.00
2,604.00
699.00
26.84%
Raw Material Cost
414.00
1,217.00
-803.00
-65.98%
Purchase of Finished goods
422.00
0.00
422.00
(Increase) / Decrease In Stocks
-37.00
-272.00
235.00
86.40%
Employee Cost
651.00
367.00
284.00
77.38%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
765.00
402.00
363.00
90.30%
Total Expenditure (Excl Depreciation)
2,215.00
1,714.00
501.00
29.23%
Operating Profit (PBDIT) excl Other Income
1,088.00
890.00
198.00
22.25%
Other Income
-13.00
88.00
-101.00
-114.77%
Operating Profit (PBDIT)
1,075.00
978.00
97.00
9.92%
Interest
45.00
6.00
39.00
650.00%
Exceptional Items
-10.00
-74.00
64.00
86.49%
Gross Profit (PBDT)
1,020.00
898.00
122.00
13.59%
Depreciation
206.00
118.00
88.00
74.58%
Profit Before Tax
814.00
780.00
34.00
4.36%
Tax
179.00
197.00
-18.00
-9.14%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
635.00
583.00
52.00
8.92%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
635.00
583.00
52.00
8.92%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
635.00
583.00
52.00
8.92%
Equity Capital
169.23
53.00
116.23
219.30%
Face Value
5.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
18.76
22.00
-3.24
-14.73%
Diluted Earnings per share
18.77
21.98
-3.21
-14.60%
Operating Profit Margin (Excl OI)
33.47%
34.18%
0.00
-0.71%
Gross Profit Margin
31.37%
34.49%
0.00
-3.12%
PAT Margin
19.53%
22.39%
0.00
-2.86%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 3,303.00 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 0.03% vs 3.90% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 17.59% vs 2.82% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 635.00 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 7.45% vs 7.85% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 26.24% vs 13.54% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,088.00 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 0.46% vs 4.94% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 19.04% vs 5.18% in Dec 2024

Quarterly - Interest
Interest 45.00 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -6.25% vs -14.29% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -21.05% vs -28.75% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 33.47%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024